CTSB and Alzheimer disease: They also highlight a comprehensive approach to clinical studies and animal models of AD, including the use of cathepsin B gene knockout and chemical inhibitors, highlighting the importance of this enzyme for new therapeutic approaches that could be used in AD (Hook et al., 2020).